---
Aliases:
---
# Monoclonal antibodies increasing availability of LDL receptor by blocking PCSK9 mediated breakdown of LDL-R
## Acts to lower LDL and Lp(a) levels by increasing availability of LDL-R on liver
## Includes:
### Evolocumab, Alirocumab
## Indications:
### Use as additive therapy with statin when goal not met with statin monotherapy
## Side effects:
### Injection site reaction
# Countra indications
# Administration 
## Subcut injection fortnightly or monthly 
# Monitering 

---
#drug 